Publication | Closed Access
An Antibody–Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma
55
Citations
22
References
2011
Year
An ADC targeting the EDNBR is highly efficacious in preclinical models of melanoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1